Sun Pharmaceutical Industries Limited
NSE: SUNPHARMA | Information Technology
Market Fundamentals
Stock Intelligence & News
Sun Pharmaceutical Industries Limited
Update on Lipitor Antitrust Litigation |SUBJECT: General Updates
Read Full Analysis →Sun Pharmaceutical Industries Ltd (524715)
Update on Lipitor Antitrust Litigation
Read Full Analysis →Sun Pharma wins U.S. antitrust appeal over Lipitor settlement
Sun Pharma wins U.S. antitrust appeal over Lipitor settlement
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Sun Pharma Faces Legal Setback Over Semaglutide Launch Amid Novo Nordisk Patent Suit
Sun Pharma's counsel argued that the potential oral product does not violate Novo Nordisk's patent rights.
Read Full Analysis →Sun Pharma Advanced Research Company Ltd (532872)
Financial Results
Read Full Analysis →Get instant alerts when SUNPHARMA breaks news
Join investors who track Sun Pharmaceutical Industries Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for SUNPHARMA?
SUNPHARMA is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Sun Pharmaceutical Industries Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding SUNPHARMA to your custom watchlist.